ArriVent BioPharma logo
ArriVent BioPharma
AVBP | NASDAQ
Chart Builder DCF Calculator
$11.56
-$1.45 (-11.15%)
At close: Nov 16, 2026, 4:00 PM ET
$11.56
$0.00 (0.00%)
After-hours: Nov 16, 2026, 7:30 PM ET

ArriVent BioPharma Statistics

Key statistics explained

Market Data

$597.92M
$204.95M
1.35
1.02M
49.53M
18.16%
N/A
NASDAQ
US04272N1028

Price Performance

-30.6%
-60.1%
-57.3%
-42.5%
-44.1%
N/A
N/A
-30.6%
-44.1%
N/A
-14.2%

Valuation

-3.16
N/A
-0.35
0.31
119.58
90.50
1.52
-3.91
-3.41
-3.74
40.99
-1.19
-1.19
-1.34
-31.7%
-25.6%
-29.3%

Financial Health

$393.22M
$256K
$393.22M
$417.09M
17.64
17.64
0.00
-0.00
-0.00
-597.04
0.00
15.07
4

Margins & Profitability

100.0%
-3620.0%
-3442.7%
-3381.4%
-3056.8%
-3501.9%
445.1%
-14.6%

Returns

-40.5%
-48.6%
-46.0%
-46.0%
-40.5%

Historical Growth (CAGR)

150.0%
N/A
N/A
-18.2%
N/A
N/A
-34.2%
N/A
N/A

Analyst Forecasts

Buy
8
14.8%
175.6%
Mar 4, 2027
-$0.96
23.1%
$6.05M
N/A

Fair Value Estimates

N/A
N/A
N/A
N/A
$27.00
133.6%

Cash Flow

$-152.84M
$-152.84M
$-175.1M
-$3.09
-$3.09
-3056.8%

Income Statement

$5M
$5M
$-181M
$-172.13M
$-169.07M
-$3.66
$64.94K
$-2.2M
77

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.